Full text is available at the source.
Abstract
Intermittent fasting may have neuroprotective potential post-stroke but faces significant clinical challenges.
- Clinical application of intermittent fasting is complicated by post-stroke catabolic stress and dysphagia, which affects about 50% of patients.
- There is a potential risk of sarcopenia associated with intermittent fasting in metabolically vulnerable patients.
- Recent findings suggest that shorter eating windows may be linked to increased mortality, raising questions about the benefits of intermittent fasting.
- The 'obesity paradox' indicates that having nutritional reserves could aid survival in stroke patients.
- Recommendations include focusing on protein-rich diets, screening for dysphagia, involving dietitians in monitoring, and considering supplements.
- Further randomized controlled trials are necessary to confirm the safety and efficacy of intermittent fasting in this population.
Simplified